These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 37858186)
1. Combination of ferroptosis and pyroptosis dual induction by triptolide nano-MOFs for immunotherapy of Melanoma. Wang S; Guo Q; Xu R; Lin P; Deng G; Xia X J Nanobiotechnology; 2023 Oct; 21(1):383. PubMed ID: 37858186 [TBL] [Abstract][Full Text] [Related]
2. A dual-pathway pyroptosis inducer based on Au-Cu Yan X; Chen C; Ren Y; Su T; Chen H; Yu D; Huang Y; Chao M; Wu G; Jiang G; Gao F Acta Biomater; 2024 Oct; 188():329-343. PubMed ID: 39278301 [TBL] [Abstract][Full Text] [Related]
3. Integration of AIEgens into covalent organic frameworks for pyroptosis and ferroptosis primed cancer immunotherapy. Zhang L; Song A; Yang QC; Li SJ; Wang S; Wan SC; Sun J; Kwok RTK; Lam JWY; Deng H; Tang BZ; Sun ZJ Nat Commun; 2023 Sep; 14(1):5355. PubMed ID: 37660063 [TBL] [Abstract][Full Text] [Related]
4. Ferroptosis/pyroptosis dual-inductive combinational anti-cancer therapy achieved by transferrin decorated nanoMOF. Xu R; Yang J; Qian Y; Deng H; Wang Z; Ma S; Wei Y; Yang N; Shen Q Nanoscale Horiz; 2021 Apr; 6(4):348-356. PubMed ID: 33687417 [TBL] [Abstract][Full Text] [Related]
5. Chemodynamic and Photothermal Combination Therapy Based on Dual-Modified Metal-Organic Framework for Inducing Tumor Ferroptosis/Pyroptosis. Deng H; Zhang J; Yang Y; Yang J; Wei Y; Ma S; Shen Q ACS Appl Mater Interfaces; 2022 Jun; 14(21):24089-24101. PubMed ID: 35588091 [TBL] [Abstract][Full Text] [Related]
6. Smart biomimetic metal organic frameworks based on ROS-ferroptosis-glycolysis regulation for enhanced tumor chemo-immunotherapy. Yang J; Ma S; Xu R; Wei Y; Zhang J; Zuo T; Wang Z; Deng H; Yang N; Shen Q J Control Release; 2021 Jun; 334():21-33. PubMed ID: 33872626 [TBL] [Abstract][Full Text] [Related]
7. Hydrazide/Metal/Indocyanine Green Coordinated Nanoplatform for Potentiating Reciprocal Ferroptosis and Immunity against Melanoma. Hou G; Qian J; Wang Y; Xu W; Guo M; Li Z; Wang J; Suo A ACS Appl Mater Interfaces; 2023 Aug; 15(31):37143-37156. PubMed ID: 37498789 [TBL] [Abstract][Full Text] [Related]
8. Photothermal Fe Li Y; Chen J; Xia Q; Shang J; He Y; Li Z; Chen Y; Gao F; Yu X; Yuan Z; Yin P J Nanobiotechnology; 2024 Oct; 22(1):630. PubMed ID: 39415226 [TBL] [Abstract][Full Text] [Related]
9. Natural product triptolide induces GSDME-mediated pyroptosis in head and neck cancer through suppressing mitochondrial hexokinase-ΙΙ. Cai J; Yi M; Tan Y; Li X; Li G; Zeng Z; Xiong W; Xiang B J Exp Clin Cancer Res; 2021 Jun; 40(1):190. PubMed ID: 34108030 [TBL] [Abstract][Full Text] [Related]
10. Disruption of dual homeostasis by a metal-organic framework nanoreactor for ferroptosis-based immunotherapy of tumor. Zhang K; Ma Z; Li S; Wu Y; Zhang J; Zhang W; Zhao Y; Han H Biomaterials; 2022 May; 284():121502. PubMed ID: 35390708 [TBL] [Abstract][Full Text] [Related]
11. Iridium(III) Photosensitizers Induce Simultaneous Pyroptosis and Ferroptosis for Multi-Network Synergistic Tumor Immunotherapy. Zeng YL; Liu LY; Ma TZ; Liu Y; Liu B; Liu W; Shen QH; Wu C; Mao ZW Angew Chem Int Ed Engl; 2024 Dec; 63(49):e202410803. PubMed ID: 39180126 [TBL] [Abstract][Full Text] [Related]
12. Cholesterol Depletion-Enhanced Ferroptosis and Immunotherapy via Engineered Nanozyme. Bai T; Xue P; Shao S; Yan S; Zeng X Adv Sci (Weinh); 2024 Oct; 11(38):e2405826. PubMed ID: 39120559 [TBL] [Abstract][Full Text] [Related]
13. Catalytically Active Metal-Organic Frameworks Elicit Robust Immune Response to Combination Chemodynamic and Checkpoint Blockade Immunotherapy. Wang X; Luo J; Wang J; Cao J; Hong Y; Wen Q; Zeng Y; Shi Z; Ma G; Zhang T; Huang P ACS Appl Mater Interfaces; 2023 Feb; 15(5):6442-6455. PubMed ID: 36700645 [TBL] [Abstract][Full Text] [Related]
14. An ultrasound-activated nanoplatform remodels tumor microenvironment through diverse cell death induction for improved immunotherapy. Ma J; Yuan H; Zhang J; Sun X; Yi L; Li W; Li Z; Fu C; Zheng L; Xu X; Wang X; Wang F; Yin D; Yuan J; Xu C; Li Z; Peng X; Wang J J Control Release; 2024 Jun; 370():501-515. PubMed ID: 38703950 [TBL] [Abstract][Full Text] [Related]
15. Biodegradable zwitterionic polymer-cloaked defective metal-organic frameworks for ferroptosis-inducing cancer therapy. Zhang M; Yao X; Xu J; Song J; Mai S; Zhu W; Zhang Y; Zhu L; Yang W Int J Pharm; 2024 Apr; 655():124032. PubMed ID: 38521374 [TBL] [Abstract][Full Text] [Related]
16. Metal-phenolic networks with ferroptosis to deliver NIR-responsive CO for synergistic therapy. Li J; Zhou Y; Liu J; Yang X; Zhang K; Lei L; Hu H; Zhang H; Ouyang L; Gao H J Control Release; 2022 Dec; 352():313-327. PubMed ID: 36272661 [TBL] [Abstract][Full Text] [Related]
17. A Triple-Responsive Polymeric Prodrug Nanoplatform with Extracellular ROS Consumption and Intracellular H Li Y; Cao Y; Ma K; Ma R; Zhang M; Guo Y; Song H; Sun N; Zhang Z; Yang W Adv Healthc Mater; 2024 Jun; 13(16):e2303568. PubMed ID: 38319010 [TBL] [Abstract][Full Text] [Related]
18. Nanoparticle delivery of miR-21-3p sensitizes melanoma to anti-PD-1 immunotherapy by promoting ferroptosis. Guo W; Wu Z; Chen J; Guo S; You W; Wang S; Ma J; Wang H; Wang X; Wang H; Ma J; Yang Y; Tian Y; Shi Q; Gao T; Yi X; Li C J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35738798 [TBL] [Abstract][Full Text] [Related]
19. The application of nanoparticles-based ferroptosis, pyroptosis and autophagy in cancer immunotherapy. Deng W; Shang H; Tong Y; Liu X; Huang Q; He Y; Wu J; Ba X; Chen Z; Chen Y; Tang K J Nanobiotechnology; 2024 Mar; 22(1):97. PubMed ID: 38454419 [TBL] [Abstract][Full Text] [Related]
20. "Multi-in-One" Yolk-Shell Structured Nanoplatform Inducing Pyroptosis and Antitumor Immune Response Through Cascade Reactions. Wang YY; Li SL; Zhang XY; Jiang FL; Guo QL; Jiang P; Liu Y Small; 2024 Jul; 20(30):e2400254. PubMed ID: 38402432 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]